written on 05.06.2014
Tags:
,

AbbVie readies production in anticipation of hep C treatment approval

TAGS: ,

AbbVie is awaiting the decisions of regulators for its closely followed new interferon-free, oral hepatitis C drug that will go head-to-head with Sovaldi. And it has lined up its production horses so that it will be ready to blast out of the gates if approvals are granted in the U.S. and Europe.

Latest Report